HER3/Akt/mTOR pathway is a key therapeutic target for the reduction of triple‑negative breast cancer metastasis via the inhibition of CXCR4 expression
Takeda, Tomoya, Tsubaki, Masanobu, Genno, Shuji, Tokunaga, Kenta, Tanaka, Remi, Nishida, Shozo
Published in International journal of molecular medicine (01.09.2023)
Published in International journal of molecular medicine (01.09.2023)
Get full text
Journal Article
Hypoxia-inducible factor 1α inhibitor induces cell death via suppression of BCR-ABL1 and Met expression in BCR-ABL1 tyrosine kinase inhibitor sensitive and resistant chronic myeloid leukemia cells
Tsubaki, Masanobu, Takeda, Tomoya, Matsuda, Takuya, Kimura, Akihiro, Tanaka, Remi, Nagayoshi, Sakiko, Hoshida, Tadafumi, Tanabe, Kazufumi, Nishida, Shozo
Published in BMB reports (28.02.2023)
Published in BMB reports (28.02.2023)
Get full text
Journal Article
Bim downregulation by activation of NF-κB p65, Akt, and ERK1/2 is associated with adriamycin and dexamethasone resistance in multiple myeloma cells
Tsubaki, Masanobu, Takeda, Tomoya, Matsuda, Takuya, Kishimoto, Kana, Tanaka, Remi, Tsurushima, Katsumasa, Ishizaka, Toshihiko, Nishida, Shozo
Published in Clinical and experimental medicine (01.09.2023)
Published in Clinical and experimental medicine (01.09.2023)
Get full text
Journal Article